Triumeq fda approval date?

When did Triumeq (abacavir/dolutegravir/lamivudine) get FDA approval?

Triumeq’s FDA approval date was August 3, 2014.[1]

What was Triumeq approved for?

Triumeq was approved for the treatment of HIV-1 infection in certain patient populations, including adults and pediatric patients who weigh at least a specified minimum and have no known resistance to the components at the time of treatment. [1]

Where can I verify the approval date and label history?

You can confirm Triumeq’s FDA approval details and related label information via the FDA product record referenced by DrugPatentWatch.[1]

Sources

1